Berends F - Search Results

1

The age of stored red blood cell concentrates at the time of transfusion.

Raat NJ, Berends F, Verhoeven AJ, de Korte D, Ince C. Raat NJ, et al. Among authors: berends f. Transfus Med. 2005 Oct;15(5):419-23. doi: 10.1111/j.1365-3148.2005.00606.x. Transfus Med. 2005. PMID: 16202057

2

Correction of subclinical coagulation disorders before percutaneous dilatational tracheotomy.

Veelo DP, Vlaar AP, Dongelmans DA, Binnekade JM, Levi M, Paulus F, Berends F, Schultz MJ. Veelo DP, et al. Among authors: berends f. Blood Transfus. 2012 Apr;10(2):213-20. doi: 10.2450/2012.0086-11. Epub 2012 Feb 13. Blood Transfus. 2012. PMID: 22337277 Free PMC article. Clinical Trial.

3

Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects.

de Jonge E, Levi M, Büller HR, Berends F, Kesecioglu J. de Jonge E, et al. Among authors: berends f. Intensive Care Med. 2001 Nov;27(11):1825-9. doi: 10.1007/s001340101107. Epub 2001 Sep 26. Intensive Care Med. 2001. PMID: 11810130 Clinical Trial.

4

Coagulation abnormalities in type 1 Gaucher disease are due to low-grade activation and can be partly restored by enzyme supplementation therapy.

Hollak CE, Levi M, Berends F, Aerts JM, van Oers MH. Hollak CE, et al. Among authors: berends f. Br J Haematol. 1997 Mar;96(3):470-6. doi: 10.1046/j.1365-2141.1997.d01-2076.x. Br J Haematol. 1997. PMID: 9054650 Free article.

5

Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects.

de Jonge E, Levi M, Berends F, van der Ende AE, ten Cate JW, Stoutenbeek CP. de Jonge E, et al. Among authors: berends f. Thromb Haemost. 1998 Feb;79(2):286-90. Thromb Haemost. 1998. PMID: 9493577 Clinical Trial.

6

Monitoring therapy with vitamin K antagonists in patients with lupus anticoagulant: effect on different tests for INR determination.

Bijsterveld NR, Middeldorp S, Berends F, Büller HR. Bijsterveld NR, et al. Among authors: berends f. J Thromb Thrombolysis. 2000 Apr;9(3):263-9. doi: 10.1023/a:1018722829498. J Thromb Thrombolysis. 2000. PMID: 10728026

7

Laboratory and clinical evaluation of an assay of thrombin-antithrombin III complexes in plasma.

Hoek JA, Sturk A, ten Cate JW, Lamping RJ, Berends F, Borm JJ. Hoek JA, et al. Among authors: berends f. Clin Chem. 1988 Oct;34(10):2058-62. Clin Chem. 1988. PMID: 3168216

8

Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

Voorberg J, Roelse J, Koopman R, Büller H, Berends F, ten Cate JW, Mertens K, van Mourik JA. Voorberg J, et al. Among authors: berends f. Lancet. 1994 Jun 18;343(8912):1535-6. doi: 10.1016/s0140-6736(94)92939-4. Lancet. 1994. PMID: 7911872

9

Monitoring anticoagulant therapy by activated partial thromboplastin time: hirudin assessment. An evaluation of native blood and plasma assays.

Nurmohamed MT, Berckmans RJ, Morriën-Salomons WM, Berends F, Hommes DW, Rijnierse JJ, Sturk A. Nurmohamed MT, et al. Among authors: berends f. Thromb Haemost. 1994 Nov;72(5):685-92. Thromb Haemost. 1994. PMID: 7900075 Clinical Trial.

10

The formation and repair of cisplatin-DNA adducts in wild-type and cisplatin-resistant L1210 cells: comparison of immunocytochemical determination with detection in isolated DNA.

Blommaert FA, Floot BG, van Dijk-Knijnenburg HC, Berends F, Baan RA, Schornagel JH, den Engelse L, Fichtinger-Schepman AM. Blommaert FA, et al. Among authors: berends f. Chem Biol Interact. 1998 Jan 30;108(3):209-25. doi: 10.1016/s0009-2797(97)00108-7. Chem Biol Interact. 1998. PMID: 9528691

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

158 results

Search Page